Literature DB >> 1829398

Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study.

S R Srinivasan1, G H Dahlen, R A Jarpa, L S Webber, G S Berenson.   

Abstract

BACKGROUND: The value of lipoprotein (a) [Lp(a)] in the prediction of coronary artery disease risk very early in life remains to be established in different racial groups. METHODS AND
RESULTS: Serum Lp(a) distribution and its relation to parental histories of myocardial infarction were examined in 2,438 children (8-17 years old) from a biracial community. Parental myocardial infarction was used as a surrogate measure of future risk of disease in the offspring. Lp(a) levels averaged 1.7-fold higher in blacks than in whites (p less than 0.0001). A small but significant sex difference (females greater than males, p less than 0.05) was seen in both races. Race was the only independent variable that contributed appreciably (9%) to the variability of Lp(a) in serum. White children with parental myocardial infarction (n = 90) had increased levels of Lp(a) compared with those without parental myocardial infarction (22.4 versus 17.1 mg/dl, p less than 0.01). Furthermore, among white children, the prevalence of parental myocardial infarction was higher in those with Lp(a) levels of more than 25 mg/dl than in those with values of 25 mg/dl or less (9.5% versus 5.4%, p less than 0.01). In contrast, the relation of Lp(a) to parental myocardial infarction was not seen in black children. No associations were observed between parental myocardial infarction and serum levels of any of the lipids or lipoprotein cholesterol classes in children of either race.
CONCLUSIONS: Serum Lp(a) levels may prove valuable in the assessment of coronary artery disease risk early in life among white populations. These findings also emphasize the need to evaluate the atherogenic potential of Lp(a) in different racial groups.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829398     DOI: 10.1161/01.cir.84.1.160

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

1.  The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans.

Authors:  V Mooser; D Scheer; S M Marcovina; J Wang; R Guerra; J Cohen; H H Hobbs
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

2.  Effect of sample storage on quantitation of lipoprotein(a) by an enzyme-linked immunosorbent assay.

Authors:  R W Evans; S S Sankey; B A Hauth; K Sutton-Tyrrell; M I Kamboh; L H Kuller
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

3.  Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis.

Authors:  Mustafa Cesur; Zeynep Ozbalkan; Mehtap Akcil Temel; Yaşar Karaarslan
Journal:  Clin Rheumatol       Date:  2006-05-06       Impact factor: 2.980

4.  Lipoprotein (a): Examination of Cardiovascular Risk in a Pediatric Referral Population.

Authors:  Omar Qayum; Noor Alshami; Chizitam F Ibezim; Kimberly J Reid; Janelle R Noel-MacDonnell; Geetha Raghuveer
Journal:  Pediatr Cardiol       Date:  2018-06-13       Impact factor: 1.655

5.  Serum bilirubin and lipoprotein-a: how are these associated with whole blood viscosity?

Authors:  E U Nwose; R S Richards; P Bwititi; E Butkowski
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

6.  Ethnic differences in lipid and lipoprotein metabolism in pregnant women of African and Caucasian origin.

Authors:  E Koukkou; G F Watts; J Mazurkiewicz; C Lowy
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

7.  Farnesoid X receptor represses hepatic human APOA gene expression.

Authors:  Indumathi Chennamsetty; Thierry Claudel; Karam M Kostner; Anna Baghdasaryan; Dagmar Kratky; Sanja Levak-Frank; Sasa Frank; Frank J Gonzalez; Michael Trauner; Gert M Kostner
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

8.  Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Salim S Virani; Ariel Brautbar; Brian C Davis; Vijay Nambi; Ron C Hoogeveen; A Richey Sharrett; Josef Coresh; Thomas H Mosley; Joel D Morrisett; Diane J Catellier; Aaron R Folsom; Eric Boerwinkle; Christie M Ballantyne
Journal:  Circulation       Date:  2011-11-29       Impact factor: 29.690

9.  Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.

Authors:  S-H Yang; S Li; Y Zhang; R-X Xu; C-G Zhu; Y-L Guo; N-Q Wu; P Qing; Y Gao; C-J Cui; Q Dong; J Sun; J-J Li
Journal:  J Endocrinol Invest       Date:  2016-02-19       Impact factor: 4.256

10.  Lipoprotein(a) in Children of Asian Indian Descendants and Their Caucasian Neighbors: The Slovak Lipid Community Study.

Authors:  R Alberty; D Albertyová
Journal:  Indian J Clin Biochem       Date:  2012-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.